SEARCH RESULTS FOR: "Tag: APTO"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(1)
2018(2)
CATEGORIES
Analyst Update(2)
Buzz Stocks(1)

1/25/2019 10:59 AM
Oppenheimer initiated coverage on Aptose Biosciences Inc (NASDAQ:APTO) with an "outperform" rating and a $6 price target -- a nearly 200% premium to last night's close -- sending the stock up 3.5% to...
11/16/2018 11:22 AM
The shares of penny stock Aptose Biosciences Inc (NASDAQ:APTO) are higher today, after B. Riley FBR initiated coverage with a "buy" rating. What's more, the analyst issued a $5 price target -- more ...
3/7/2018 10:12 AM
Drugmakers Aptose Biosciences Inc (NASDAQ:APTO) and Esperion Therapeutics Inc (NASDAQ:ESPR) are both making headlines this morning, but for different reasons. We'll dig into APTO and ESPR stocks b...
PEOPLE ALSO SEARCH FOR

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center